Abstract: An essential oil mixture for fighting varroa parasites, the essential oil mixture has 15% to 25% wood vinegar by volume of the entire mixture, 25% to 35% thyme oil by volume of the entire mixture, 25% to 35% aniseed oil by volume of the entire mixture, 8 to 13% clove oil by volume of the entire mixture, 3 to 8% cardamom oil by volume of the entire mixture, and 3 to 8% peppermint oil by volume of the entire mixture. The essential oil mixture is placed in a container such that vapors from the essential oil mixture are released in an area adjacent to the vaporizer device.

Abstract: Provided herein are methods and compositions for stabilization of active agents. The active agents are distributed, mixed or embedded in a silk fibroin matrix, thereby retaining the bioactivity of the active agents upon storage and/or transportation. In some embodiments, the storage-stable vaccine-silk compositions are also provided herein.

Abstract: A solid cosmetic which contains 1 to 30% by mass of (A) a solid oil component having a melting point of 50 to 120° C., 50 to 95% by mass % of (B) a liquid oil component, 3 to 40% by mass % of (C) a nonionic surfactant having an HLB value of 5 to 13, 0.1 to 20% by mass % of (D) a powder having a volume average particle diameter of 1 to 200 ?m, and 0.1 to 10% by mass of (E) fumed silica is excellent in cleansing property, washing-off property and refreshing feeling after washing, and is also excellent in quality stability such as appearance and uniformity of composition.

Abstract: A solid W/O stable composition comprising a gellifying system comprising at least one hydrophobic gelling agent and at least one hydrophilic gelling agent and an emulsifying system comprising at least one surfactant having HLB value of 14 or less. Further there is disclosed a method of treatment keratinous surface with the inventive composition.

Abstract: The invention discloses a nutrient solution formula for inhibiting green algae, comprising a basic nutrient solution and an algae inhibitory substance, wherein the basic nutrient solution comprises major elements, minor elements and trace elements. The specific ratio is: 1000 mg/L of calcium nitrate, 1000 mg/L of potassium nitrate, 200 mg/L of EDTA-FeNa, 200 mg/L of potassium dihydrogen phosphate, 150 mg/L of ammonium dihydrogen phosphate, 700 mg/L of magnesium sulfate, 7 mg/L of boric acid, 5 mg/L of manganese sulfate, 15 mg/L of ferrous sulfate, 0.25 mg/L of copper sulfate, 0.22 mg/L of zinc sulfate, 0.02 mg/L of ammonium molybdate, and 0.01 mg/L of benzalkonium chloride. The benzalkonium chloride can provide Cl ions, and it has a good bactericidal and algae-killing ability in different pH value ranges; the optimal dosage is 0.01 mg/L.

Abstract: Disclosed are a sustained-release injection formulation containing a biodegradable polymer double microcapsule that contains a conjugate of poly-L-lactic acid (hereinafter referred to as “PLLA”) filler and hyaluronic acid (hereinafter referred to as “HA”) and is capable of controlling the release rate of PLLA, and a method of preparing the same.

Abstract: A concentrate composition comprising: (a) at least 0.1 wt % of a surfactant compound; and (b) at least 10 wt % one or more ingredients selected from aldehydes, succinimidyl esters, chelating agents and amine salts of carboxylic acids.

Abstract: The present invention relates to the treatment or prevention of conditions linked to reduced muscle mass or reduced muscle protein synthesis rate. A subject matter of the invention is a composition comprising complexes of whey protein micelles and pectin for use in the treatment or prevention of a condition selected from the group consisting of sarcopenia, muscle atrophy and negative nitrogen balance. Further aspects of the invention relate to the non-therapeutic use of a composition comprising complexes of whey protein micelles and pectin and a food composition.

Abstract: The invention relates to bone repair and more specifically to a berberine/mineralized collagen-based composite membrane, a preparation method, and an application thereof. The composite membrane includes a berberine nanofiber membrane and a mineralized collagen membrane disposed on a unilateral surface of the berberine nanofiber membrane. The mineralized collagen with biomimetic mineralization capacity is combined with a Chinese materia medica monomer, berberine, the resulting bilayer composite membrane has a better effect on promoting osteogenesis In addition, a novel dosage form of berberine is constructed. An electrospinning method prepares a berberine nanofiber membrane. The berberine nanofibers are received by the mineralized collagen membrane, or after the berberine nanofiber membrane is obtained, a mineralized collagen membrane is prepared by applying on the surface of the berberine nanofiber membrane.

Abstract: The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated ORC fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent; spraying the suspension through a nozzle onto a substrate, allowing the non-aqueous solvent to evaporate; separating from the substrate and sieving the composition.

Abstract: The present disclosure provides for suspension-based pharmaceutical formulations for cold and flu medications, specifically suspension formulations and soft gel capsule dosage forms having reduced size. The present disclosure also provides methods of preparing the suspensions and soft gel capsule dosage forms.

Abstract: An exosome-based skincare product containing exosomes excreted by lab cultured human umbilical mesenchymal stem cells within a solvent. Most frequently the solvent is a mixture of water and glycerin. Optional ingredients such as skin-conditioning agents, antioxidants, surfactants, buffering agents, viscosity decreasing agents, viscosity increasing agents, peptides, binders, and/or humectants may be included.

Abstract: A saline nasal cleansing solution comprising: a water component; a humectant component; a salt component; a cleansing component; a surfactant component; a gelling component; a preservative component; an antioxidant component; and one or more natural extracts; wherein the cleansing component is ppg-26-butanol polyether-26; wherein the humectant component is sorbitol; wherein the salt component is sodium chloride; wherein the surfactant component is PEG-40 hydrogenated castor oil.

Abstract: The subject matter of the invention is a carrier loaded with bioactive substances, wherein the carrier is carbonate substituted hydroxyapatite and the bioactive substances are an ion and a plant extract, wherein the ion is selected from the group consisting of Cu, Zn and a combination thereof, and wherein the plant extract consists of mint extract, rosemary extract, Ocimum basilicum extract, lemon extract, garlic extract, clove extract, thyme extract and cinnamon extract.

Abstract: Disclosed herein are hair care compositions and methods of using same. The compositions may be substantially anhydrous, and optically clear. The hair care compositions, when mixed with water, create an exothermic reaction, for example, when mixed with hair that has been pre-wetted. The mixture with water further causes the composition to become opaque, much like a traditional conditioning agent. The compositions may be left on the wetted hair and subjected to heat for enhanced treatment of the hair.

Abstract: A method for applying a cosmetic composition to skin is disclosed. The method can include applying a first composition to skin that includes at least about 50% by weight of a volatile hydrocarbon, a film former, a solvent comprising an ester group, and a combination of ultraviolet A (UVA) and ultraviolet B (UVB) sunscreen agents, wherein the UVA sunscreen agent comprises 4-tert-butyl-4?-methoxydibenzoylmethane, wherein the first composition has an SPF of at least about 15 and a PFA of at least about 5, and wherein the first composition dries within two minutes after topical application to skin, and subsequently applying the cosmetic composition onto the first composition.

Abstract: The present technology generally relates to an encapsulation system for delivery of an active agent, the encapsulation system comprising a matrix of microcapsules, wherein a first portion of microcapsules in the matrix of microcapsules has an average diameter of from about 0.1 microns to about 10 microns; a second portion of the microcapsules has an average diameter of from about 10 microns to about 100 microns; and a third portion of the microcapsules has an average diameter of from about 100 microns to about 500 microns; and wherein the active agent is encapsulated in the microcapsules.

Abstract: Disclosed herein are a biodegradable polymer microparticle for a filler comprising a core and a shell, wherein the core contains secondary particles including aggregates of a plurality of primary particles, the shell has a raspberry shaped structure, an average particle diameter (D50) of the biodegradable polymer microparticle ranges from 20 to 200 ?m, a manufacturing method thereof, a freeze-dried body including the same, and filler injection including the same.

Abstract: The low aqueous solubility of roflumilast in parenteral preparations and topical emulsions, suspensions, gels or solutions can be improved by including a blend of water-miscible solvents in the pharmaceutical composition. The blend of water-miscible solvents can include diethylene glycol monoethyl ether (Tradename Transcutol®; abbreviated DEGEE) and water. The ratio of diethylene glycol monoethyl ether to water is from 1:10 to 20:1. The resulting composition has improved bioavailability and efficacy and can be used to inhibit phosphodiesterase 4 in a patient in need of such treatment.

Abstract: In an embodiment, the present disclosure relates to a composition for treating or preventing a skin condition. In some embodiments, the composition includes zinc oxide with a concentration between about 5 and 30 wt/wt %, coconut oil with a concentration between about 0.1 and 5 wt/wt %, tea tree oil with a concentration between about 0.00025 and 0.1 wt/wt %, citronella oil with a concentration between about 0.00025 and 0.1 wt/wt %, and lemongrass oil with a concentration between about 0.01 and 1 wt/wt %. In a further embodiment, the present disclosure pertains to a composition for treating or preventing a skin condition including zinc oxide with a concentration of about 24 wt/wt %, coconut oil with a concentration of about 1 wt/wt %, tea tree oil with a concentration of about 0.001 wt/wt %, citronella oil with a concentration of about 0.001 wt/wt %, and lemongrass oil with a concentration of about 0.08 wt/wt %.